Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-06-17 4:30 pm Unchanged | 2022-06-15 | 13D | Crescent Biopharma, Inc. CBIO | SINGER JULIAN D. | 5,108 6.400% | 0 (Unchanged) | Filing History |
| 2022-05-25 5:01 pm Purchase | 2022-05-24 | 13D | Crescent Biopharma, Inc. CBIO | SINGER JULIAN D. | 5,108 6.400% | 1,781 (+53.51%) | Filing History |
| 2022-05-10 4:58 pm Unchanged | 2022-05-09 | 13D | Crescent Biopharma, Inc. CBIO | SINGER JULIAN D. | 3,328 4.170% | 0 (Unchanged) | Filing History |
| 2022-05-02 5:27 pm Unchanged | 2022-04-28 | 13D | Crescent Biopharma, Inc. CBIO | SINGER JULIAN D. | 3,328 4.170% | 0 (Unchanged) | Filing History |
| 2022-04-21 1:09 pm Unchanged | 2022-04-20 | 13D | Crescent Biopharma, Inc. CBIO | SINGER JULIAN D. | 3,328 4.170% | 0 (Unchanged) | Filing History |
| 2022-03-16 08:00 am Unchanged | 2022-03-15 | 13D | Crescent Biopharma, Inc. CBIO | SINGER JULIAN D. | 3,328 4.180% | 0 (Unchanged) | Filing History |
| 2022-03-07 3:53 pm Unchanged | 2022-03-04 | 13D | Crescent Biopharma, Inc. CBIO | SINGER JULIAN D. | 3,328 4.180% | 0 (Unchanged) | Filing History |
| 2022-03-04 5:23 pm Purchase | 2022-02-22 | 13G | Crescent Biopharma, Inc. CBIO | LYTTON LAURENCE W | 4,726 5.900% | 4,430 (+1493.26%) | Filing History |
| 2022-02-28 1:16 pm Purchase | 2022-02-24 | 13D | Crescent Biopharma, Inc. CBIO | SINGER JULIAN D. | 3,328 4.180% | 182 (+5.78%) | Filing History |
| 2022-02-22 7:04 pm Purchase | 2022-02-22 | 13D | Crescent Biopharma, Inc. CBIO | SINGER JULIAN D. | 3,146 3.950% | 1,167 (+58.99%) | Filing History |
| 2022-02-14 4:39 pm Sale | 2021-12-31 | 13G | Crescent Biopharma, Inc. CBIO | ACUTA CAPITAL PARTNERS LLC | 0 0.000% | -3,442 (Position Closed) | Filing History |
| 2022-02-14 08:05 am Purchase | 2021-12-31 | 13G | Crescent Biopharma, Inc. CBIO | Nantahala Capital Management, LLC | 7,002 8.800% | 2,272 (+48.05%) | Filing History |
| 2022-02-11 5:55 pm Sale | 2021-12-31 | 13G | Crescent Biopharma, Inc. CBIO | Stonepine Capital Management, LLC | 0 0.000% | -5,438 (Position Closed) | Filing History |
| 2022-02-11 4:18 pm Purchase | 2021-12-31 | 13G | Crescent Biopharma, Inc. CBIO | ORBIMED ADVISORS LLC | 3,424 4.300% | 3,424 (New Position) | Filing History |
| 2022-02-11 4:16 pm Purchase | 2021-12-27 | 13G | Crescent Biopharma, Inc. CBIO | Renaissance Technologies LLC | 4,492 5.640% | 3,988 (+790.41%) | Filing History |
| 2022-01-27 11:56 am Unchanged | 2022-01-26 | 13D | Crescent Biopharma, Inc. CBIO | SINGER JULIAN D. | 1,979 2.480% | 0 (Unchanged) | Filing History |
| 2022-01-18 06:15 am Sale | 2022-01-14 | 13G | Crescent Biopharma, Inc. CBIO | Assenagon Asset Management S.A. | 0 0.000% | -4,759 (Position Closed) | Filing History |
| 2022-01-18 06:12 am Purchase | 2022-01-13 | 13G | Crescent Biopharma, Inc. CBIO | Assenagon Asset Management S.A. | 4,759 5.980% | 1,933 (+68.39%) | Filing History |
| 2022-01-05 5:29 pm Purchase | 2022-01-04 | 13D | Crescent Biopharma, Inc. CBIO | SINGER JULIAN D. | 1,979 2.480% | 304 (+18.17%) | Filing History |
| 2021-10-25 9:08 pm Purchase | 2021-10-25 | 13D | Crescent Biopharma, Inc. CBIO | SINGER JULIAN D. | 1,674 2.110% | 663 (+65.59%) | Filing History |